VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OLMA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
OLMAOlema Pharmaceuticals, Inc.
$12.20$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksOLMAQuarterly Financials

Olema Pharmaceuticals, Inc. (OLMA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Olema Pharmaceuticals, Inc. (OLMA) quarterly income statement — complete revenue, gross profit & net income history

OLMA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold119K187K000000000000000000
COGS % of Revenue--------------------
Gross Profit-119K-187K000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses57.87M49.9M45.88M47.86M34.87M36.77M37.62M33.53M34.34M30.42M23.34M21.6M29.6M27.22M23.22M33.29M23.25M21.76M17.76M16.52M
OpEx % of Revenue--------------------
Selling, General & Admin8.63M6.86M5.93M3.96M4.25M4.47M4.39M4.42M4.46M4.54M3.89M3.61M6.78M5.63M5.59M6.24M7.25M5.78M5.24M4.61M
SG&A % of Revenue--------------------
Research & Development49.23M43.22M39.95M43.9M30.62M32.3M33.23M29.11M29.88M25.87M19.45M17.99M22.83M21.58M17.63M27.05M16.01M15.97M12.52M11.91M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-57.99M-50.08M-45.88M-47.86M-34.87M-36.77M-37.62M-33.53M-34.34M-30.42M-23.34M-21.6M-29.6M-27.22M-23.22M-33.29M-23.25M-21.76M-17.76M-16.52M
Operating Margin %--------------------
Operating Income Growth %-66.28%-36.22%-21.95%-42.75%-1.56%-20.88%-61.17%-55.22%-16%-11.75%-0.52%35.12%-27.3%-25.1%-30.74%-101.51%-50.51%-114.76%-125.75%-
EBITDA-57.87M-49.9M-45.83M-47.73M-34.74M-36.65M-37.53M-33.44M-34.25M-30.33M-23.25M-21.5M-29.5M-27.12M-23.13M-33.21M-23.17M-21.68M-17.71M-16.49M
EBITDA Margin %--------------------
EBITDA Growth %-66.55%-36.14%-22.14%-42.76%-1.44%-20.85%-61.39%-55.5%-16.1%-11.82%-0.52%35.25%-27.33%-25.08%-30.6%-101.37%-50.06%-114.12%-125.17%-
D&A (Non-Cash Add-back)119K187K43K132K128K116K95K94K88K88K90K99K100K97K91K85K84K73K50K31K
EBIT-57.99M-50.08M-42.22M-47.86M-34.87M-36.77M-37.62M-33.53M-34.34M-30.42M-23.34M-21.6M-29.6M-27.22M-23.22M-33.29M-23.25M-21.64M-17.76M-16.52M
Net Interest Income4.78M4.01M3.65M4.04M4.52M3.29M2.93M3.11M3.35M3.55M1.92M1.55M1.3M973K622K415K218K109K105K117K
Interest Income4.78M4.01M3.65M4.04M4.52M3.29M2.93M3.11M3.35M3.55M1.92M1.55M1.3M973K622K415K218K109K105K117K
Interest Expense00000000000000000000
Other Income/Expense4.9M4.02M3.66M4.08M4.48M3.2M3.07M3.15M3.37M3.64M1.84M1.51M1.32M1.04M502K435K224K119K49K116K
Pretax Income-53.09M-46.06M-42.22M-43.78M-30.39M-33.57M-34.55M-30.38M-30.97M-26.77M-21.5M-20.09M-28.29M-26.18M-22.72M-32.86M-23.03M-21.64M-17.71M-16.41M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-53.09M-46.06M-42.22M-43.78M-30.39M-33.57M-34.55M-30.38M-30.97M-26.77M-21.5M-20.09M-28.29M-26.18M-22.72M-32.86M-23.03M-21.64M-17.71M-16.41M
Net Margin %--------------------
Net Income Growth %-74.7%-37.22%-22.17%-44.11%1.88%-25.38%-60.71%-51.19%-9.49%-2.27%5.36%38.84%-22.82%-20.99%-28.27%-100.28%-50.14%-113.58%-125.82%-
Net Income (Continuing)-53.09M-46.06M-42.22M-43.78M-30.39M-33.57M-34.55M-30.38M-30.97M-26.77M-21.5M-20.09M-28.29M-26.18M-22.72M-32.86M-23.03M-21.64M-17.71M-16.41M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.52-0.51-0.49-0.51-0.36-0.57-0.60-0.54-0.56-0.49-0.48-0.49-0.67-0.63-0.55-0.82-0.57-0.54-0.45-0.42
EPS Growth %-44.44%10.53%18.33%5.56%35.71%-16.33%-25%-10.2%16.42%22.22%12.73%40.24%-17.54%-16.67%-22.22%-95.24%-46.15%-8%-114.29%-
EPS (Basic)-0.52-0.50-0.49-0.51-0.36-0.57-0.60-0.54-0.56-0.49-0.48-0.49-0.67-0.63-0.55-0.82-0.57-0.54-0.45-0.42
Diluted Shares Outstanding102.8M91.32M85.73M85.5M85.43M58.74M57.26M56.28M55.57M54.78M44.98M40.72M40.35M40.19M40.04M39.92M39.83M39.74M39.61M39.42M
Basic Shares Outstanding102.8M91.32M85.73M85.5M85.43M58.74M57.26M56.28M55.57M54.78M44.98M40.72M40.35M40.19M40.04M39.92M39.83M39.74M39.61M39.42M
Dividend Payout Ratio--------------------